José L. Arias

Dr. José L. Arias

Faculty of Veterinary Sciences, University of Chile, 88208-08 Santiago, Chile

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2008 in Chemical Reviews
Verified
Journal Article
Closed access
José L. AriasJosé L. Arias
José L. Arias
MFMaría S. Fernández
María S. Fernández

24 August 2010 in Nanomedicine
Verified
Journal Article
Closed access
SGSimon Guerrero
Simon Guerrero
EAEyleen Araya
Eyleen Araya
JFJenny L Fiedler
Jenny L Fiedler
José L. AriasJosé L. Arias
José L. Arias
CACarolina Adura
Carolina Adura
MKMarcelo Kogan
Marcelo Kogan
Background & Aims: Gold nanoparticles (GNPs) have promising applications for drug delivery as well as for the diagnosis and treatment of several pathologies, such as those related to the CNS. Howev...

15 June 2004 in Journal of Materials Chemistry
Verified
Journal Article
Closed access
PDF file
JAJosé L. Arias
José L. Arias
ANAndrónico Neira-Carrillo
Andrónico Neira-Carrillo
José L. AriasJosé L. Arias
José L. Arias
CECarla Escobar
Carla Escobar
MBMarcia Bodero
Marcia Bodero
MFMaría S. Fernández
María S. Fernández
Biomineralization leads to the formation of inorganic crystals with unique, ordered, refined shapes that are regulated by specific macromolecules. This process has been a source of inspiration for exploring novel approaches to the fabrication of inorganic-based surfaces and interfaces. Among those macromolecules, sulfated polymers, referred to as proteoglycans, have not received enough attention, although there is increasing evidence of their widespread occurrence in biominerals. Here we examine the available information on the nature, distribution and possible role of sulfated polymers in biomineralization, and highlight new directions to stimulate further research activities.

1 November 2006 in Journal of Structural Biology
Verified
Journal Article
Closed access
Alejandro Rodriguez-NavarroAlejandro Rodriguez-Navarro
Alejandro Rodriguez-Navarro
CCChristiane CabraldeMelo
Christiane CabraldeMelo
NBNelson Batista
Nelson Batista
NMNilton Morimoto
Nilton Morimoto
PAPedro Alvarez
Pedro Alvarez
José L. AriasJosé L. Arias
José L. Arias

20 May 2008 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
José L. AriasJosé L. Arias
José L. Arias
AGA Gonzalez
A Gonzalez
MFM S Fernandez
M S Fernandez
CARLOS M GONZALEZCARLOS M GONZALEZ
CARLOS M GONZALEZ
DSD Saez
D Saez
JAJ L Arias
J L Arias
The efficiency of chicken eggshell membranes combined with a minimally invasive small osteotomy procedure of the ulna to accomplish an efficient release of the radius so that it can continue to grow in an unstressed manner was tested in rabbits. Eggshell membranes were extracted from chicken eggs, rinsed, dried and sterilized with ethylene oxide for 24 h. For reactivity testing, four separate subcutaneous pockets were created in 10 rats in the paravertebral region by blunt dissection and eggshell membranes were implanted in two of them. After 1–16 weeks, the implants were retrieved with the surrounding soft tissues and submitted to histological examination. Subsequently, 10 rabbits were anaesthetized and a complete 0.5 mm wide osteotomy was performed in both the right and the left distal ulna. A piece of eggshell membranes was interposed in the osteotomy site of one ulna. The opposite osteotomized ulna was left as a negative control. The rabbits were injected with oxytetracycline at the time of surgery and this was repeated every 7 days for labelling new bone formation. After 1–16 weeks, ulnar osteotomized regions were histologically examined. After histological, fluorescence microcopy and radiological evaluation, we demonstrate here for the first time that eggshell membranes as interpositional material in rabbit osteotomized ulnar experiments acted as an active barrier against bone bridging. The degradation of the eggshell membrane, due to host reaction, appeared sufficiently late to cause the desirable delay of bone healing that is compatible with the time needed for a corrective response. Copyright © 2008 John Wiley & Sons, Ltd.

16 June 2017 in Oncology Letters
Verified
Journal Article
Open access
PDF file
MIMaría Iturriaga
María Iturriaga
RPRodolfo Paredes
Rodolfo Paredes
José L. AriasJosé L. Arias
José L. Arias
CTCristian Torres
Cristian Torres
Cyclooxygenase (COX)-2 expression is positively correlated with malignant features in canine mammary carcinomas. Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit COX activity and may therefore possess anticancer effects. Meloxicam is an NSAID that is widely used in human and veterinary medicine. High concentrations of meloxicam have been reported to be antitumorigenic in vitro; however, the effect of meloxicam at concentrations that are equivalent to those that can be obtained in vivo remains unknown. In the current study, the in vitro effects of low-dose meloxicam (0.25 µg/ml) on CF41.Mg canine mammary carcinoma cells were evaluated. The effects on cell proliferation, apoptosis, cell migration and invasion, in addition to the expression of different molecules associated with tumor invasiveness were analyzed. No effect on cell viability and apoptosis were observed. However, cell migration and invasion were significantly reduced following treatment with meloxicam. MMP-2 expression and activity were similarly reduced, explaining the impaired cell invasion. In addition, β-catenin expression was downregulated, while its phosphorylation increased. These results indicate that 0.25 µg/ml meloxicam reduces cell migration and invasion, in part through modulating MMP-2 and β-catenin expression. Additional studies are required to elucidate the mechanism associated with the anti-invasive effect of meloxicam on CF41.Mg cells. The results of the present study suggest that meloxicam has a potential adjunctive therapeutic application, which could be useful in controlling the invasion and metastasis of canine mammary carcinomas.